chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Was real sick for about 4-5 days; Fever; Stomachache; Body aches; This is a spontaneous report from a contactable consumer. An unspecified age male patient received first dose of bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration on unknown date at single dose for covid-19 immunization. Medical history included she says she wondered if it was a reaction, because she was sick, with aching arms, and aches all over, and she is wondering if she should get second shot. The patient's concomitant medications were not reported. It was reported that Consumer says that she and her husband went somewhere to have their first COVID-19 vaccine and are due again for the second dose on 11Feb, which is next Thursday. Caller says she has been having a reaction, and they called the paramedics, but they said that there was no need to take her to the hospital, and knew what it was. Caller says she had fever, stomachache, and body aches. Caller says something about 11 days she is supposed have second shot, it is due 11Feb. Unable to clarify with caller as she continued speaking. Caller says she was told to call here and called her doctor and he said he had the same thing as a reaction from his too, and she was told to take Tylenol and drink a lot of liquids. She says she wondered if it was a reaction, because she was sick, with aching arms, and aches all over, and she is wondering if she should get second shot. Caller(s) clarify it was the paramedic guy, and not her doctor, who said he had been real sick for about 4-5 days after getting his first dose of the vaccine. The outcome of the events "Unknown".  Information on the lot/ batch number has been requested.
Pt received Smallpox inoculation secondary to negative HCG. Pt received Positive HCG 2 wks ago indicating pregnancy during Smallpox inoculation. According to HCG results pt was one mo pregnant.
Acute kidney injury, nephrotic syndrome, acute interstitial nephritis, minimal change disease, focal proliferative glomerulonephritis
lymph nodes swollen in armpit, pain, lump at injection site, patient arm sore
severe watery diarrhea; This is a spontaneous report from a contactable consumer or other non hcp.   An 84-years-old female Non pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 10:30 (Batch/Lot Number: EN5318) as dose 2, single dose for covid-19 immunisation. Medical history included cardiac disorder. Concomitant medication(s) included atenolol (ATENOLOL); diltiazem (DILTIAZEM) apixaban (ELIQUIS); furosemide (FUROSEMIDE); potassium (POTASSIUM) taken for unspecified indication. The patient previously took Augmentin bambini and experienced drug hypersensitivity, Mutlaq and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm right on 29Jan2021 03:45 PM (Batch/Lot Number was EN5318) as single dose for covid-19 immunisation.The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID.It was Reported that, the patient experienced severe watery diarrhoea on 27Feb2021 12:00 with outcome of recovered. Therapeutic measures were taken as a result of severe watery diarrhoea.  No follow-up attempts are needed. No further information is expected.
diarrhea; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), HEADACHE (headache) and NAUSEA (nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DIARRHOEA (diarrhea), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Pt fainted and a few minutes after given the FLUVIRIN 14-15 vaccine. He was our for not even a minutes. Got up on his own, sat for 15 minutes. Then left with his mom.
extremely tired; Initial information was received on 11-Sep-2023 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (Patient).  This case involves an unknown age male patient who was extremely tired after receiving INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (Suspension for injection) (strength, expiry date, lot number not reported via unknown route in unknown administration site for Prophylactic Vaccination (Immunization). The information on batch number was requested.  On an unknown date the patient developed extremely tired (fatigue) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  It was reported that " It is unknown to the reporter which specific Fluzone variant the consumer took. At the time of the report, the consumer took Fluzone about 4 days ago. "  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (extremely tired).  At time of reporting, the outcome was Not Recovered / Not Resolved for the event extremely tired.
pt recv vax 1Apr96&3Apr96 om &cranky had runny nose;8apr96 devel temp&measles-like rash on trunk;11apr96 devel erythema,big hives&welts all over body;purpura vasculitis, pt's face&body were swollen;dx vasculitis&erythema multi;
Plantar fasciitis; Lymphocytosis; White blood cell 130,000; sore heel; Deep vein thrombosis; Lower immunoglobulin G/Lower (20); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4316223-00.  A 75-year-old male patient received bnt162b2 (BNT162B2), intramuscular at an unspecified date (Batch/Lot number: unknown) at an unspecified age as dose 1, single, intramuscular at an unspecified date (Batch/Lot number: unknown) at an unspecified age as dose 2, single and intramuscular at an unspecified date (Batch/Lot number: unknown) at an unspecified age as dose 3 (booster), single for covid-19 immunisation; jnj 78436735 (COVID-19 VACCINE NRVV AD26 (JNJ 78436735)), intramuscular at an unspecified date (Batch/Lot number: unknown) at an unspecified age as dose number unknown, single for covid-19 immunisation; ibrutinib (IMBRUVICA), oral at an unspecified date (Batch/Lot number: unknown) for chronic lymphocytic leukaemia. Relevant medical history included: "Chronic Lymphocytic Leukemia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DEEP VEIN THROMBOSIS (medically significant), outcome "unknown", described as "Deep vein thrombosis"; BLOOD IMMUNOGLOBULIN G DECREASED (medically significant) with onset 2022, outcome "unknown", described as "Lower immunoglobulin G/Lower (20)"; PLANTAR FASCIITIS (medically significant), outcome "unknown", described as "Plantar fasciitis"; LYMPHOCYTOSIS (medically significant), outcome "unknown", described as "Lymphocytosis"; WHITE BLOOD CELL COUNT ABNORMAL (medically significant), outcome "unknown", described as "White blood cell 130,000"; PAIN IN EXTREMITY (medically significant), outcome "unknown", described as "sore heel". The patient underwent the following laboratory tests and procedures: blood immunoglobulin g (Immunoglobulin G): (2022) lower (20); sars-cov-2 antibody test (COVID-19 antibody test): (unspecified date) negative; white blood cell count (White Blood Cell): (unspecified date) 130000, notes: no units. The action taken for ibrutinib was unknown. Therapeutic measures (Eliquis and Medrol) were taken as a result of deep vein thrombosis, blood immunoglobulin g decreased, plantar fasciitis, lymphocytosis, white blood cell count abnormal, pain in extremity. The reporter's causality between the suspect drug ibrutinib (IMBRUVICA) and the events was not provided. The reporter's causality between the suspect drugs jnj 78436735 (COVID-19 VACCINE NRVV AD26 (JNJ 78436735)) and bnt162b2 (BNT162B2) and the events was not reported  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received vaccine on 10-9-15. One week passed and pt experienced severe arm and shoulder pain. Also complained of extreme Gerd. Sx's subsided 1 month. On 1-1-16 Pain returned after catching a cold.
Immediately after vaccination, the patient's arm began to swell at the injection site. The skin was slightly discolored (green/blue like a bruise). The patient may have gotten a hematoma/bruise at the injection site. Patient denied pain, or other symptoms (no shortness of breath, no itchiness, no throat swelling). Patient reported feeling mildly "woozy" 45 minutes afterwards.
This report described the occurrence of a chronic cough in a 58 year old female who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received from the subject and has not been verified by a physician or any other healthcare professional. The subject's medical history reportedly included SOB after exercising. Concurrent medications included an unspecified "stomach medicine." The subject stated that she had no adverse experiences following previous immunizations. On an unspecified date in September 2002, the subject received her first injection of Engerix B. She received her second injection on an unspecified date in October 2002. She reported that she started to cough "since beginning the Engerix B series." She was examined by a physician, who did not find a cause for the cough. A chest x-ray "was negative." The subject used non-prrescription cough suppressants and "prescription therapy" without relief. She reported that the cough was only relieved by taking one-half tablet of Vicodin.
On Oct. 6, 2021 I could not sleep well. The injection site was red hot and swelling. I was in pain. It hurt like crazy. A Knot appeared on my left arm, it was four inches long. This on top of my arm. It was a long knot 5 inches long and 4 inches wide. It also relocated. It was feverish and long. I went to the clinic and they said it was COVID Arm. I went to the doctor and he said the injection looked as if they missed the muscle. My doctor told me not to get the second shot, until I came back home from vacation. There is still a small knot on top of my arm. I plan on getting my second shot, but I will get Moderna. My doctor said it was okay for me to switch. I put ice packs, took Tylenol for fever and laid in bed. It has gotten better.
NIGHT SWEATS; VERY WEAK; This spontaneous report received from company representative via social media concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced night sweats, and very weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the very weak and night sweats was not reported. This report was non-serious.
Pt developed hives/rash all over body the day after receiving vaccine. Took diphenhydramine by mouth. Which helped. Then developed rash at injection site. Was told to continue diphenhydramine. Rash cleared after 1 week.
Fever 12/30/06 max 102F after vaccines today. Seizure like activity with fever. Taken to Emergency Room. 2/2/07 Received medical records from hospital ER which reveal patient experienced fever & seizure activity for approx 1 min following vax x 4 on 12/30.  Had been well for week prior to vax & no sick contacts.  Temp in ER was 102.3. Tx w/antipyretcis in ER.  D/C to home w/o further seizure activity. FINAL DX: Viral syndrome &  possible febrile seizure.
Pregnancy; Was to Receive a Hep-B Booster (not HEPLISAV-B but the GSK Brand); Initial Report Received on 03-Nov-2022 and 04-Nov-2022 (Safety received 14-Mar-2023)   The colleague of a patient reported to the Pregnancy Registry that a patient (age, race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization while more than 30 weeks pregnant.  No relevant medical history was reported.    No relevant concomitant medications were reported.    On an unspecified date, the patient received a dose of HEPLISAV-B (Lot #, expiration date and NDC # not reported). The route and site was not provided. The patient was more than 30 weeks pregnant and was to receive a hepatitis B vaccine booster (GSK), not HEPLISAV-B.   The Pregnancy Registry attempted to follow-up with the reporter on 18 Nov 2022 whether the patient was interested in enrolling in the Registry and left a message. Permission for Dynavax to follow-up with the patient was not obtained.  No additional information was provided.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Got covid-19 after vaccination; A spontaneous report was received from other health professional concerning a male patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and tested positive for covid-19.  The patient's medical history and concomitant medication were not reported.  On 04-Jan-2021 prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) via intramuscular route for prophylaxis of COVID-19 infection.   A few days after the vaccine administration, the patient had sore throat, cough and body aches. Hence, on 08-Jan-2021, he went to the physician and had a strep test and covid-19 test. He did not have strep; but, however, he was positive for covid-19. No treatment information was provided.  Action taken with the mRNA-1273 in response to the event was not provided.   The outcome of event got covid-19 after vaccination was considered unknown.; Reporter's Comments: Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related.
3 days after the shot I got a rash on my chest and neck. I sent a message to the Doctor and she referred me to dermatology. The rash has spread all over my body. They have done multiple biopsies. They said it was something I came in contact with. We have nothing in our house and didn?t come into contact with anything new. The only new thing I came into contact with was the shot. I am still dealing with this horrible itchy rash.
Started coughing and felt throat closing. Took Benadryl and went to bed at 11 pm. Slept 10 hours and awoke with a headache and swollen eyes. Was in bed most of the day sleeping.
Left upper thigh with redness; no induration. Treated with Duricef oral antibiotics.
Dizziness Narrative: About one hour after shot, developed dizziness, which continues at this time (2 hours). Hasn't fallen, gait is stable, hasn't taken any meds.
arm started shaking and wouldn't stop; fingers went completely numb; formed a scab which fell/started scratching on her arm and that formed a scab which fell; felt really dizzy; she had soreness/felt like she was run over by a truck; chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (arm started shaking and wouldn't stop), HYPOAESTHESIA (fingers went completely numb), SCAB (formed a scab which fell/started scratching on her arm and that formed a scab which fell), DIZZINESS (felt really dizzy) and PAIN (she had soreness/felt like she was run over by a truck) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history and relevant lab data was provided.  Concomitant products included LISINOPRIL and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced TREMOR (arm started shaking and wouldn't stop), HYPOAESTHESIA (fingers went completely numb), SCAB (formed a scab which fell/started scratching on her arm and that formed a scab which fell), DIZZINESS (felt really dizzy), PAIN (she had soreness/felt like she was run over by a truck) and CHILLS (chills). At the time of the report, TREMOR (arm started shaking and wouldn't stop), HYPOAESTHESIA (fingers went completely numb), SCAB (formed a scab which fell/started scratching on her arm and that formed a scab which fell), DIZZINESS (felt really dizzy), PAIN (she had soreness/felt like she was run over by a truck) and CHILLS (chills) outcome was unknown.            She got done an EEG and came up with no signs of seizure, also had a MRI showing no signs of stroke, just little things related to aging. She had blood work too that came up being normal.   This case was linked to MOD-2021-259875 (Patient Link).
Severe pain lasting to date 13 months. Significant weakness.  MRI on Aug 23  showed fluid build up in shoulder.  MRI on March 9, 2020 showed muscle on back side of rotator cuff showed major deterioration and the doctor said it was ?dying?.  Surgery in April 2020 on impacted shoulder has had no discernible improvement. On going (2 days a week and at home) has had no discernible improvement. Pain and weakness have actually gotten worse.
Patient had red round rash area on arm where vaccine was administered - measured 2.9 x 1.7.
I am experiencing more intense side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (I am experiencing more intense side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (I am experiencing more intense side effects). At the time of the report, ADVERSE REACTION (I am experiencing more intense side effects) outcome was unknown.            No concomitant medications reported. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Initial report was received 13 October 2011 via a company sponsored web site from a consumer, who is also the patient. A female patient who was two year-old at the time of the event had received the PERTUSSIS VACCINE (manufacturer, lot number, route, site and date of administration not reported) and within 10 minutes, experienced a "sesure" (seizure) that lasted for 45 minutes. According to the patient, "now that I'm older I have slow learning problems". No further information was available at the time of the report. Outcome is not recovered. Documents held by sender: none.
Approx 1 week and 2 days ago, pt was here for vaccinations and was discharged home. Today she comes in with complaints of swelling in left leg which had increased in size, in the past 2 days, from pea-sized to 3 1/2cm X 2cm. The area was very red and irritated but otherwise, no adverse signs and symptoms.
EDD 8/20/21- 21 weeks pregnant Swollen lymph nodes in armpit, pain in lymph nodes
Information has been received from a pharmacist as relayed by a physician concerning a patient (age and gender not reported) who on approximately 02-OCT-2007 "3 weeks ago" was vaccinated with ZOSTAVAX. On approximately 23-OCT-2007 ("3 weeks after administration of vaccine") the patient experienced "mild shingles appearance at the injection site". The physician examined patient on 23-OCT-2007 and prescribed an unspecified treatment. The patient's outcome was reported as not recovered. Additional has been requested.
Injection site is hot; Injection site is itchy; Swelling on injection arm; Injection site is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site is hot), VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE SWELLING (Swelling on injection arm) and VACCINATION SITE ERYTHEMA (Injection site is red) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 10218467) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site is hot), VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE SWELLING (Swelling on injection arm) and VACCINATION SITE ERYTHEMA (Injection site is red). At the time of the report, VACCINATION SITE WARMTH (Injection site is hot), VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE SWELLING (Swelling on injection arm) and VACCINATION SITE ERYTHEMA (Injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment medication was not provided.
Body aches; Congestion; Sore throat; Sinus headache; Fever; This is a spontaneous report from a contactable other healthcare professional, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Sep2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 09Sep2021, the patient experienced fever, body aches, congestion, sore throat, and sinus headache. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, body aches, congestion, sore throat, and sinus headache was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.